Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Blueprint Medicines Corp as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 248
- −30 vs. Q4 2021
- Shares held
- 59.8M
- +788.4K (+1.3%) vs. Q4 2021
- Total value
- $3.82B
- −$2.50B (−39.5%) vs. Q4 2021
- New holders
- 34
- 85 more added
- Sold out
- 64
- 91 more reduced
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPMC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $129 |
| Q1 2026 | 6 | $38.6K |
| Q4 2025 | 8 | $2.57M |
| Q3 2025 | 12 | $2.58M |
| Q2 2025 | 356 | $8.65B |
| Q1 2025 | 353 | $6.12B |
| Q4 2024 | 346 | $5.86B |
| Q3 2024 | 319 | $6.04B |
| Q2 2024 | 305 | $7.15B |
| Q1 2024 | 282 | $6.25B |
| Q4 2023 | 260 | $5.91B |
| Q3 2023 | 220 | $3.25B |
| Q2 2023 | 222 | $4.03B |
| Q1 2023 | 215 | $2.84B |
| Q4 2022 | 223 | $2.74B |
| Q3 2022 | 240 | $4.15B |
| Q2 2022 | 237 | $3.19B |
| Q1 2022 | 248 | $3.82B |
| Q4 2021 | 280 | $6.32B |
| Q3 2021 | 289 | $6.13B |
| Q2 2021 | 281 | $5.14B |
| Q1 2021 | 264 | $5.69B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Blueprint Medicines Corp; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Anfield Capital Management, LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Smith Group Asset Management, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| Resolute Partners Group | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Tygh Capital Management, Inc. | – | – | – | – | Not filed |
| Harbour Investments, Inc. | – | – | – | – | Not filed |